LINJARDY MXR 25/5/1000MG TAB

LINJARDY MXR is a combination tablet containing empagliflozin, linagliptin, and metformin HCl. This triple-action formulation is designed to help manage type 2 diabetes by improving blood sugar control through multiple mechanisms. Empagliflozin works by increasing glucose excretion, linagliptin enhances insulin secretion, and metformin reduces hepatic glucose production. Each tablet delivers 25mg empagliflozin, 5mg linagliptin, and 1000mg metformin HCl for comprehensive glycemic management. Suitable for patients requiring multi-drug therapy to achieve optimal diabetes control.